E. Reid, Bryan Scales, I. D. Wilson
Bioactive Analytes, Including CNS Drugs, Peptides, and Enantiomers
E. Reid, Bryan Scales, I. D. Wilson
Bioactive Analytes, Including CNS Drugs, Peptides, and Enantiomers
- Gebundenes Buch
Andere Kunden interessierten sich auch für
- E. ReidBIOACTIVE ANALYTES, Including CNS Drugs, Peptides, and Enantiomers42,99 €
- V.V. Krongauz (ed.) / A.D. TrifunacProcesses in Photoreactive Polymers192,99 €
- Polymers in Medicine and Surgery42,99 €
- R. M. BrownCellulose and Other Natural Polymer Systems85,99 €
- James E MarkPhysical Properties of Polymers Handbook724,99 €
- I. Ya SlonimThe NMR of Polymers37,99 €
- Steven E. KeinathOrder in the Amorphous "state" of Polymers152,99 €
-
-
-
Produktdetails
- Methodological Surveys in Biochemistry and Analysis 16A
- Verlag: Springer / Springer US / Springer, Berlin
- Artikelnr. des Verlages: 978-0-306-42400-7
- 1987.
- Seitenzahl: 422
- Erscheinungstermin: 31. Januar 1987
- Englisch
- Gewicht: 960g
- ISBN-13: 9780306424007
- ISBN-10: 0306424002
- Artikelnr.: 24481020
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
#A Peptides and Other Endogenous-Type Analytes.- #A-1 Assays of peptidoglycans and specific antibodies in biological samples.- #A-2 Cyclic decapeptides in kidney.- #A-3 Analysis of protein growth factors and optimization of their separation by HPLC.- #A-4 HPLC-EC measurement of neuropeptides in biological samples.- #A-5 Determination of substance P and neurokinins by a combined HPLC/RIA procedure.- #A-6 Methods and problems in the assay of CSF for ?-endorphin and other endogenous peptides.- #A-7 The importance of defined tracers in RIA.- #A-8 The use of radioimmunoassays for cryptic regions of peptide precursors, in the study of biosynthetic mechanisms.- #A-9 Clinical assay of somatomedins by RIA.- #A-10 Immunometric approach to peptide hormone analysis.- #B CNS-Active Drugs and Their Metabolites.- #B-1 Thirty years of antipsychotic drug analysis.- #B-2 Determination of benzodiazepines: the present-day scene.- #B-3 Analytical pitfalls with tricyclic and newer antidepressants in biological samples.- #B-4 Determination of phenothiazines: the present-day scene.- #B-5 Analysis of thioxanthenes by HPTLC, HPLC, capillary GC, and RIA.- #B-6 HPLC-EC determination of physostigmine in biological samples.- #B-7 HPLC-UV determination of substituted benzamides in biological fluids for their pharmacokinetic study.- #C Separation Technology Applicable to Various Drugs and to Enantiomers.- #C-1 Novel capillary gas-chromatographic phases applicable to drugs.- #C-2 Liquid-solid sample preparation.- #C-3 Applicability of HPLC chiral stationary phases to pharmacokinetic and disposition studies on enantiomeric drugs.- #C-4 Attempts to obtain separations of chiral anticholinergic drugs.- #D Approaches to Analyte Detection, Identification and Measurement.- #D-1 The application of highresolution proton NMR spectroscopy to the detection of drug metabolites in biological samples.- #D-2 Detection, identification and quantitative analysis of drugs by 1H NMR.- #D-3 Pre-column (HPLC) fluorescence labelling of glucuronides.- #D-4 Photodiode array HPLC detectors in metabolic profiling and other analytical screening techniques.- #D-5 A rotating filter disc alternative to photodiode array detection systems.- Analyte Index.- General Index.
#A Peptides and Other Endogenous-Type Analytes.- #A-1 Assays of peptidoglycans and specific antibodies in biological samples.- #A-2 Cyclic decapeptides in kidney.- #A-3 Analysis of protein growth factors and optimization of their separation by HPLC.- #A-4 HPLC-EC measurement of neuropeptides in biological samples.- #A-5 Determination of substance P and neurokinins by a combined HPLC/RIA procedure.- #A-6 Methods and problems in the assay of CSF for ?-endorphin and other endogenous peptides.- #A-7 The importance of defined tracers in RIA.- #A-8 The use of radioimmunoassays for cryptic regions of peptide precursors, in the study of biosynthetic mechanisms.- #A-9 Clinical assay of somatomedins by RIA.- #A-10 Immunometric approach to peptide hormone analysis.- #B CNS-Active Drugs and Their Metabolites.- #B-1 Thirty years of antipsychotic drug analysis.- #B-2 Determination of benzodiazepines: the present-day scene.- #B-3 Analytical pitfalls with tricyclic and newer antidepressants in biological samples.- #B-4 Determination of phenothiazines: the present-day scene.- #B-5 Analysis of thioxanthenes by HPTLC, HPLC, capillary GC, and RIA.- #B-6 HPLC-EC determination of physostigmine in biological samples.- #B-7 HPLC-UV determination of substituted benzamides in biological fluids for their pharmacokinetic study.- #C Separation Technology Applicable to Various Drugs and to Enantiomers.- #C-1 Novel capillary gas-chromatographic phases applicable to drugs.- #C-2 Liquid-solid sample preparation.- #C-3 Applicability of HPLC chiral stationary phases to pharmacokinetic and disposition studies on enantiomeric drugs.- #C-4 Attempts to obtain separations of chiral anticholinergic drugs.- #D Approaches to Analyte Detection, Identification and Measurement.- #D-1 The application of highresolution proton NMR spectroscopy to the detection of drug metabolites in biological samples.- #D-2 Detection, identification and quantitative analysis of drugs by 1H NMR.- #D-3 Pre-column (HPLC) fluorescence labelling of glucuronides.- #D-4 Photodiode array HPLC detectors in metabolic profiling and other analytical screening techniques.- #D-5 A rotating filter disc alternative to photodiode array detection systems.- Analyte Index.- General Index.